Andrew Kuske analyst CREDIT SUISSE

Currently out of the existing stock ratings of Andrew Kuske, 56 are a BUY (44.09%), 67 are a HOLD (52.76%), 4 are a SELL (3.15%).

Andrew Kuske

Work Performance Price Targets & Ratings Chart

Analyst Andrew Kuske, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 40.29% that have a potential upside of 56.07% achieved within 869 days.

Andrew Kuske’s has documented 205 price targets and ratings displayed on 20 stocks. The coverage is on Utilities, Energy, Basic Materials, Financial Services sectors.

Most recent stock forecast was given on ENB, Enbridge at 13-Sep-2023.

Wall Street Analyst Andrew Kuske

Analyst best performing recommendations are on BN (BROOKFIELD CORP).
The best stock recommendation documented was for MERC (MERCER INTERNATIONAL) at 1/10/2022. The price target of $12.5 was fulfilled within 60 days with a profit of $2.17 (21.01%) receiving and performance score of 3.5.

Average potential price target upside

BBU Brookfield Business Partners LP BEP Brookfield Renewable Partners LP BIP Brookfield Infrastructure Partners LP ENB Enbridge MERC Mercer International PBA Pembina Pipeline Corp TAC TransAlta Corp TRP TC Energy Corp AQN Algonquin Power & Utilities Corp BAM Brookfield Asset Management FTS Fortis NPIFF Northland Power WFG West Fraser Timber Co Ltd OSB Norbord BN Brookfield Corp GBNXF Gibson Energy BR Broadridge Financial Solutions CD Chindata Group Holdings Ltd ING ING Group NV ADR TRS TriMas

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Sep-2020

$40

$6.89 (20.81%)

$39

5 months 30 days ago
(02-Feb-2026)

7/9 (77.78%)

$3.71 (10.22%)

569

Buy Since 18-Jun-2025

$44

$10.89 (32.89%)

$33

5 months 30 days ago
(02-Feb-2026)

1/2 (50%)

$7.71 (21.25%)

105

Buy Since 08-Feb-2021

$42

$8.89 (26.85%)

$38

8 months 25 days ago
(07-Nov-2025)

7/10 (70%)

$11.02 (35.57%)

433

Buy Since 05-May-2025

$31

$-2.11 (-6.37%)

$59

1 years 2 months 27 days ago
(05-May-2025)

1/2 (50%)

$9.46 (43.92%)

143

Buy Since 03-Feb-2025

$30

$-3.11 (-9.39%)

1 years 5 months 29 days ago
(03-Feb-2025)

1/1 (100%)

$8.67 (40.65%)

234

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Andrew Kuske?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?